Surgery Partners (NASDAQ:SGRY – Get Free Report) is set to post its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Surgery Partners to post earnings of $0.07 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last posted its quarterly earnings data on Monday, February 26th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. The business had revenue of $735.40 million during the quarter, compared to analysts’ expectations of $741.93 million. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. The business’s revenue was up 4.0% on a year-over-year basis. During the same period last year, the firm posted $0.22 earnings per share. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Surgery Partners Stock Performance
SGRY opened at $24.53 on Monday. The business has a 50 day moving average price of $27.63 and a two-hundred day moving average price of $29.79. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.71 and a quick ratio of 1.57. The company has a market capitalization of $3.12 billion, a price-to-earnings ratio of -245.30, a price-to-earnings-growth ratio of 2.24 and a beta of 2.75. Surgery Partners has a 1-year low of $22.05 and a 1-year high of $45.79.
Insider Buying and Selling at Surgery Partners
Analyst Ratings Changes
A number of brokerages recently weighed in on SGRY. Citigroup reduced their target price on shares of Surgery Partners from $43.00 to $42.00 and set a “buy” rating for the company in a report on Tuesday, February 27th. Barclays assumed coverage on Surgery Partners in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $35.00 target price on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Wednesday, April 10th. Royal Bank of Canada restated an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a report on Thursday, February 29th. Finally, Benchmark reiterated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a report on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $43.63.
Check Out Our Latest Report on Surgery Partners
About Surgery Partners
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
See Also
- Five stocks we like better than Surgery Partners
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 4/29 – 5/3
- Why Invest in High-Yield Dividend Stocks?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 3 Warren Buffett Stocks to Buy Now
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.